You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – other biologic treatment
AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tanaka E, Inoue E, Hoshi D, et al
AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database
Annals of the Rheumatic Diseases 2013;71:668.